CNC:NYSE
Centene Corp
$68.00
arrow_downward
-1.66%(-1.15) 1D
Oct 19, 2:24:58 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CNC...
Open
$69.19
High
$70.34
Low
$67.55
Mkt. cap
33.62B
Avg. vol.
4.55M
Volume
1.43M
52-wk high
$71.21
52-wk low
$31.63
EPS
-$10.44
Beta
1.13
Shares outstanding
494.00M
No. of employees
61K
Open
$69.19
High
$70.34
Low
$67.55
Mkt. cap
33.62B
Avg. vol.
4.55M
Volume
1.43M
52-wk high
$71.21
52-wk low
$31.63
EPS
-$10.44
Beta
1.13
Shares outstanding
494.00M
No. of employees
61K
News stories
From web sources and news partners
ChartMill
·
27 minutes ago
Most Active S&P 500 Stocks on Oct. 19
KuCoin
·
44 minutes ago
The Dow finished last week up 0.7%. Most of the stock market
TradingView
·
59 minutes ago
Midday Pulse: S&P 500 top intraday gainers
www.tokenpost.com
·
1 hour ago
S&P 500 and Nasdaq Rise Amid Uneven Black Monday Anniversary Trading
Profile
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500. Wikipedia
About Centene Corp
CEOSarah M. London
Employees61.1K
Founded1984
HeadquartersSt. Louis, Missouri, United States
SectorHealth care provider
Websitecentene.com
Analyst ratings
Based on 14 analysts giving stock ratings to CNC in the past 3 months
Buy
Buy
6
Hold
8
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CNC in the last 3 months.
Highest
Current $68.00
$80.00 (+17.65%)
Average
$72.92 (+7.24%)
Lowest
$65.00 (-4.41%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ben Hendrix RBC Capital | Hold | Maintained | $71.00 | +4.4% | 10/07/2026 |
Lance Wilkes Bernstein | Buy | Maintained | $79.00 | +16.2% | 10/05/2026 |
Kevin Fischbeck Bank of America Securities | Buy | Reiterated | $80.00 | +17.6% | 09/24/2026 |
Andrew Mok CFA Barclays | Buy | Maintained | $80.00 | +17.6% | 09/17/2026 |
Stephen Baxter Wells Fargo | Hold | Maintained | $69.00 | +1.5% | 09/15/2026 |
John Stansel J.P. Morgan | Hold | Reiterated | $67.00 | -1.5% | 08/20/2026 |
John Staszak Argus Research | Buy | Upgraded | $80.00 | +17.6% | 08/10/2026 |
Sarah James Cantor Fitzgerald | Buy | Reiterated | $75.00 | +10.3% | 07/28/2026 |
Erin Wright Morgan Stanley | Hold | Maintained | $66.00 | -2.9% | 07/29/2026 |
Jason Cassorla Guggenheim | Hold | Maintained | - | - | 07/28/2026 |
David S Macdonald Truist Financial | Buy | Reiterated | $80.00 | +17.6% | 07/29/2026 |
A.J. Rice UBS | Hold | Maintained | $70.00 | +2.9% | 07/29/2026 |
Michael Ha Robert W. Baird | Hold | Maintained | $66.00 | -2.9% | 07/29/2026 |
Ryan Langston TD Cowen | Hold | Reiterated | $65.00 | -4.4% | 07/30/2026 |
Joanna Gajuk Bank of America Securities | Buy | Maintained | $74.00 | +8.8% | 07/17/2026 |
Ann Hynes Mizuho Securities | Hold | Maintained | $69.00 | +1.5% | 07/13/2026 |
George Hill Deutsche Bank | Buy | Upgraded | $80.00 | +17.6% | 05/20/2026 |
Scott Fidel Goldman Sachs | Sell | Maintained | $40.00 | -41.2% | 04/29/2026 |
Michael Wiederhorn Oppenheimer | Buy | Reiterated | $58.00 | -14.7% | 04/29/2026 |
David Windley Jefferies | Hold | Maintained | $39.00 | -42.6% | 04/20/2026 |
Next call in 8 days
Tue, Oct 27, 2:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.10
Revenue / Est. (USD)
- / 46.98B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 45.35B | 45.09B | 45.06B | 44.81B |
Cost of goods sold | 40.90B | 41.49B | 38.30B | 39.03B |
Cost of revenue | 40.90B | 41.49B | 38.30B | 39.03B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 3.14B | 3.35B | 3.38B | 3.05B |
Operating expense | 4.20B | 4.45B | 4.48B | 4.10B |
Total operating expenses | 45.10B | 45.94B | 42.78B | 43.12B |
Operating income | 248.00M | -847.00M | 2.28B | 1.68B |
Other non operating income | - | - | - | - |
EBT including unusual items | -6.67B | -1.54B | 2.10B | 1.49B |
EBT excluding unusual items | 78.00M | -1.02B | 2.12B | 1.53B |
Income tax expense | -42.00M | -443.00M | 560.00M | 399.00M |
Effective tax rate | 0.63% | 28.71% | 26.68% | 26.85% |
Other operating expenses | 745.00M | 771.00M | 794.00M | 745.00M |
Net income | -6.63B | -1.10B | 1.54B | 1.09B |
Net profit margin | -14.62% | -2.44% | 3.42% | 2.43% |
Earnings per share | 0.50 | -1.19 | 3.37 | 2.51 |
Interest and investment income | - | - | - | - |
Interest expense | -170.00M | -168.00M | -164.00M | -153.00M |
Net interest expenses | -170.00M | -168.00M | -164.00M | -153.00M |
Depreciation and amortization charges | 147.00M | 160.00M | 134.00M | 139.00M |
EBITDA | 565.00M | -518.00M | 2.58B | 1.98B |
Gain or loss from assets sale | - | 501.00M | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1